Melle, Germany

Peter Ellinghaus

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Wuppertal, DE (2004 - 2010)
  • Melle, DE (2012 - 2014)

Company Filing History:


Years Active: 2004-2014

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Peter Ellinghaus: Innovator in Pharmaceutical Chemistry

Introduction

Peter Ellinghaus is a notable inventor based in Melle, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating hyper-proliferative disorders and diseases associated with angiogenesis. With a total of five patents to his name, Ellinghaus has established himself as a key figure in his area of expertise.

Latest Patents

Ellinghaus's latest patents include innovative compounds that have the potential to revolutionize treatment options. One of his notable inventions is the "Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis." This invention focuses on novel heteroaryl substituted pyrazole compounds, pharmaceutical compositions containing these compounds, and their use in treating hyper-proliferative and/or angiogenesis disorders, either as a sole agent or in combination with other active ingredients or therapeutic measures. Another significant patent is "Substituted heterocyclylbenzylpyrazoles and use thereof." This application relates to novel substituted 1-[3-(heterocyclyl)benzyl]-1H-pyrazole derivatives, detailing processes for their preparation and their use in the treatment and prevention of diseases, particularly those arising from metabolic adaptation to hypoxic states.

Career Highlights

Throughout his career, Peter Ellinghaus has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Intellectual Property GmbH and Bayer Schering Pharma AG, where he has contributed to various research and development projects. His work has focused on creating effective treatments for complex medical conditions, showcasing his dedication to advancing healthcare solutions.

Collaborations

Ellinghaus has collaborated with several professionals in his field, including Michael Härter and Hartmut Beck. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical chemistry.

Conclusion

Peter Ellinghaus is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the treatment of hyper-proliferative disorders and diseases associated with angiogenesis. His contributions through patents and collaborations reflect his commitment to improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…